Director/PDMR Shareholding

RNS Number : 9589N

MyCelx Technologies Corporation

21 May 2015

 



MyCelx Technologies Corporation   

("MyCelx" or the "Company") (AIM: MYX)

21 May 2015

Grant of Share Option to Director

The Company announces that it has been notified on 20 May 2015 by Mark Clark, Chief Financial Officer and a director of the Company, that he was granted an option on 20 May 2015 under the MyCelx Omnibus Performance Incentive Plan ("Plan") over the Company's common shares of US$0.025 each ("Common Shares"). The grant to Mr. Clark was as follows:

Name of Director	Number of share options granted	Exercise price	Total number of share options held following this notification	Total number of share options as % of current issued share capital
Mark Clark	20,000	US$2.15 *	81,667	0.44%

In addition, following this transaction, Mr. Clark continues to be interested in 47,553 Common Shares, representing 0.26 per cent of the present issued capital of the Company.

Grant of Share Option to Chief Business Development Officer

The Company further announces that it has been notified on 20 May 2015 by Connie Mixon, Chief Executive Officer and a director of the Company, that her husband Mark Mixon, Chief Business Development Officer, was granted an option on 20 May 2015 under the Plan over 76,000 Common Shares. The grant to Mr. Mixon was as follows:

Name	Number of share options granted	Exercise price	Total number of share options held following this notification	Total number of share options as % of current issued share capital
Mark Mixon	76,000	US$2.15 *	200,204	1.07%

In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as custodian for his son.

Following this transaction, Ms. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,210 Common Shares, representing 5.32 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 363,221 Common Shares, representing 1.95 per cent of the present issued capital of the Company.

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.

The above grants formed part of wider grants of 319,000 options to a total of fifteen employees across the Company, on the same date, representing 1.71% of the current issued share capital.  

The share options granted on 20 May 2015 will vest as to one third on each of the first, second and third anniversaries of the date of grant, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.

*Based on the mid-market closing price of the Company's Common Shares at 19 May 2015, and the closing US/£ exchange rate at that date.

For further information please contact:

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

Tel: [phone]

Numis Securities Limited

Corporate Finance 

John Prior

Paul Gillam

Corporate Broking

James Black

Ben Stoop

Tel: [phone]

Bell Pottinger

Nick Lambert

Henry Lerwill

Tel: [phone]

 

END

 

 

RDSLLFEVETILFIE